Company intelligence / Profile preview

iCare

Ownership: Private
Development stage: Commercial

Overview

iCare is a global leader in ophthalmic diagnostics, offering commercialized products for retinal imaging, perimetry with retinal tracking, and handheld rebound tonometers. Their technologies are widely used by eye care professionals to diagnose and monitor diseases like glaucoma, diabetic retinopathy, and macular degeneration. The company’s solutions are available in over 100 countries worldwide.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on iCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iCare.

Explore the full profile